Levels of lipoprotein(a) and plasma lipids in Spanish children aged from 4 to 18 years

Acta Paediatrica, International Journal of Paediatrics

Volumn 85, Issue 1, 1996, Pages 38-42

  Gomez Gerique J A ^a,b   Porres, A ^a   Lopez Martinez D ^a   Alvarez Sala, L A ^a   Blazquez, E ^a   Montoya, M T ^a   De Oya, M ^a  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^b Bioquímica Clínica   (Spain)

Author keywords

Cardiovascular disease; Lipoprotein(a)

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ARTICLE; CARDIOVASCULAR DISEASE; CHILD; CHILDHOOD; HAZARD; HUMAN; LIPID BLOOD LEVEL; NORMAL HUMAN; NORMAL VALUE; PRIORITY JOURNAL; SPAIN;

EID: 0030038945     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.1996.tb13887.x     Document Type: Article

References (30)

1. Kostner GM, Krempler F. Lipoprotein(a). Curr Opin Lipidol 1992;3:279-84
2. Bihari-Varga M, Kostner GM, Czinner A. Lp(a) and the risk of coronary heart disease. Eur J Epidemiol 1992;8(suppl 1):33-5
3. Sandkamp M, Assmann G. Lipoprotein(a) in PROCAM participants and young myocardial infarction survivors. In: Scanu AM, editor. Lipoprotein(a): 25 years progress, New York: Academic Press, 1990:183-204.
4. Hoefler G, Harnoncourt F, Paschke E, Mirtl W, Pfeiffer KH, Kostner GM. Lipoprotein Lp(a). A risk factor for myocardial infarction. Arteriosclerosis 1988;8:398-401
5. Cambillau M, Simon A, Amar J, et al. Serum Lp(a) as a discriminant marker of early atherosclerotic plaques at three extra-coronary sites in hypercholesterolemic men. Arterioscl Thromb 1992;12:1346-52
6. Rath M, Niendorf A, Reblin T, Dietel M, Krebber HJ, Beisiegel U. Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary by-pass patients. Arteriosclerosis 1989;9:579-92
7. Beisiegel U. Lipoprotein(a) in the arterial wall. Curr Opin Lipidol 1991;2:317-23
8. Berg K. A new serum system in man: the Lp system. Acta Pathol Microbiol Scand 1963;59 Suppl:369-82
9. Sommer A, Gorges R, Kostner GM, Paltauf F, Hermetter A. Sulfhydryl-selective fluorescence labeling of lipoprotein(a) reveals evidence for one single disulfide linkage between apoproteins (a) and B-100. Biochemistry 1991;30:11245-9
10. Gaubatz JW, Heideman C, Gotto AM Jr, Morrisett JD, Dahlen GH. Human plasma lipopoprotein [a]: structural properties. J Biol Chem 1983;258:4582-9
11. Scanu AM. Update on Lp(a). Curr Opin Lipidol 1991;2:253-8
12. Utermann G, Duba C, Menzel HJ. Genetics of the quantitative Lp(a) lipoprotein trait. II: Inheritance of Lp(a) glycoprotein phenotypes. Hum Genet 1988;78:47-50
13. Boerwinkle E. Genetics of plasma lipoprotein (a) concentrations. Curr Opin Lipidol 1992;3:128-36
14. Mensink RP, Zock PL, Katan MB, Hornstra G. Effect of dietary cis-and trans-fatty acids on serum lipoprotein(a) levels in humans. J Lipid Res 1992;33:1493-501
15. Gurakar A, Hoeg JM, Kostner GM, Papadopoulos NM, Brewer HB. Levels of lipoprotein(a) decline with neomycin and niacin treatment. Atherosclerosis 1985;57:293-301
16. Crook D, Sidhu M, Seed M, O'Donnell M, Stevenson JC. Lp(a) levels are reduced by danazol and anabolic steroids. Atherosclerosis 1992;92:41-7
17. Levitsky L, Scanu AM, Gould S. Lipoprotein(a) levels in black and white children and adolescents with IDDM. Diabetes Care 1991;14:283-7
18. Haffner S, Tuttle K, Rainwater D. Decrease of lipoprotein(a) with improved glycemic control in IDDM subjects. Diabetes Care 1991;14:302-7
19. Wang XL, Wilcken DL, Dudman NP. Neonatal apo A-I, apo-B and apo(a) levels in dried blood spots in an Australian population. Pediatr Res 1990;28:496-501
20. Srinivasan SR, Dahlen GH, Jarpa RA, Webber LS, Berenson GS. Racial (black-white) differences in serum lipoprotein (a) distribution and its relation to parental myocardial infarction in children. Bogalusa Heart Study. Circulation 1991;84:160-7
21. Wilcken DE, Wang XL, Greenwood J, Lynch J. Lipoprotein (a) in children and apolipoproteins B and A-I in children and coronary vascular events in their grandparents. J Pediatr 1993;123:519-26
22. Kostner GM, Czinner A, Pfeiffer KH, Bihari-Varga M. Lipoprotein(a) concentrations as risk indicators for atherosclerosis. Arch Dis Child 1991;66:1054-6.
23. Assmann G, Schriewer H, Schmitz G, Hagele D. Quantification of high density lipoprolein cholesterol by precipitation with phosphotungstic acid. Clin Chem 1983;29:2026-30
24. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502
25. Vella JC, Jover E, Relation of lipoprotein(a) in 11 to 19 year-old adolescents to parental cardiovascular heart disease. Clin Chem 1993;39:477-80
26. Wilcken DE, Wang XL, Dudman N. Early expression of the apolipoprotein(a) gene: relationships between infants and their parents serum apolipoprotein(a) levels. Pediatrics 1992;89:401-6
27. Henriksson P, Angelin B, Berglund L. Hormonal regulation of serum Lp(a) levels. Opposite effects after estrogen treatment and orchidectomy in males with prostatic carcinoma. J Clin Invest 1992;89:1166-71
28. Taimela S, Viikari JSA, Porkka KVK and Dahlen GH. Liporotein(a) levels in children and young adults:the influence of physical activity. The Cardiovascular Risk in Young Finns Study. Acta Paediatr 1994;86:1258-63.
29. Scanu AM, Lawn RM, Berg K. Lipoprotein(a) and atherosclerosis. Ann Int Med 1991;115:209-18
30. Sandkamp M, Funke H, Schulte H, Köhler E, Assmann G. Lipoprotein (a) is an independent risk factor for myocardial infarction at a young age. Clin Chem 1990;36:20-3